Security key
09075P204
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI)
CUSIP: 09075P204
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 21,847,524
- Total 13F shares
- 603,081
- Share change
- +224,098
- Total reported value
- $1,090,541
- Price per share
- $1.81
- Number of holders
- 33
- Value change
- +$395,829
- Number of buys
- 14
- Number of sells
- 13
Report period
Q2 2025
Institutions
33
Top holders
10
BTAI full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
BioXcel Therapeutics, Inc. SEC filings
BioXcel Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 09075P204
Recent filing periods:
Top shareholders of BTAI - BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13D/G
|
— |
5%
|
288,131
|
$564,737 | -$9,229,922 | 31 Mar 2025 | |
| Oaktree Capital Group Holdings GP, LLC |
13D/G
|
Oaktree Capital Holdings, LLC |
2.7%
|
170,230
|
$28,939 | -$434,154 | 31 Mar 2025 | |
| Murchinson Ltd. |
13F
|
Company |
0.62%
|
136,076
|
$276,234 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.47%
|
101,778
|
$206,609 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.11%
|
24,794
|
$50,332 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.11%
|
23,241
|
$47,179 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.1%
|
22,062
|
$44,793 | — | 31 Mar 2025 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
0.09%
|
18,845
|
$38,255 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.09%
|
18,824
|
$38,213 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.06%
|
12,293
|
$24,955 | — | 31 Mar 2025 | |
| Virtu Financial LLC |
13F
|
Company |
0.05%
|
10,666
|
$22,000 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0.01%
|
1,910
|
$3,877 | — | 31 Mar 2025 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0.01%
|
1,884
|
$3,823 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
1,766
|
$3,585 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
1,519
|
$3,084 | — | 31 Mar 2025 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
1,273
|
$2,584 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
851
|
$1,728 | — | 31 Mar 2025 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0%
|
237
|
$481 | — | 31 Mar 2025 | |
| AllSquare Wealth Management LLC |
13F
|
Company |
0%
|
175
|
$355 | — | 31 Mar 2025 | |
| Washington Trust Advisors, Inc. |
13F
|
Company |
0%
|
160
|
$325 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
152
|
$309 | — | 31 Mar 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
116
|
$235 | — | 31 Mar 2025 | |
| Parkside Financial Bank & Trust |
13F
|
Company |
0%
|
112
|
$228 | — | 31 Mar 2025 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0%
|
103
|
$209 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
44
|
$89 | — | 31 Mar 2025 | |
| NewEdge Advisors, LLC |
13F
|
Company |
0%
|
31
|
$63 | — | 31 Mar 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0%
|
27
|
$54 | — | 31 Mar 2025 | |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO |
13F
|
Company |
0%
|
21
|
$43 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
11
|
$22 | — | 31 Mar 2025 | |
| Farther Finance Advisors, LLC |
13F
|
Company |
0%
|
5
|
$10 | — | 31 Mar 2025 | |
| DANSKE BANK A/S |
13F
|
Company |
0%
|
3
|
$6 | — | 31 Mar 2025 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
3
|
$6 | — | 31 Mar 2025 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
1
|
$2 | — | 31 Mar 2025 | |
| Rashmi Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,554,945
|
$187,267,747 | — | 03 Apr 2023 | |
| Vipin Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,554,945
|
$187,267,747 | — | 03 Apr 2023 | |
| Indu R. Gupta |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,550,396
|
$187,168,169 | — | 03 Apr 2023 | |
| Tarun K. Gupta |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,550,396
|
$187,168,169 | — | 03 Apr 2023 | |
| Suganthi Balasubramanian |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,547,750
|
$187,110,248 | — | 03 Apr 2023 | |
| Anita Jain |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,547,300
|
$187,100,398 | — | 03 Apr 2023 | |
| Diwakar Jain |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,547,300
|
$187,100,398 | — | 03 Apr 2023 | |
| Krishnan Nandabalan |
3/4/5
|
Director, 10%+ Owner |
—
mixed-class rows
|
8,840,750
mixed-class rows
|
$187,088,358 | — | 06 Apr 2023 | |
| Akrati Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Alka Sood |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Anesha Agarwal |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Bina Jatin Patel |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| BioXcel Holdings, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 25 Jun 2021 | |
| BioXcel LLC |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 25 Jun 2021 | |
| Jatin Markand Patel |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Krunal Dilip Patel |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 | |
| Marshal D. Gibson |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
8,546,750
|
$187,088,358 | — | 03 Apr 2023 |
Institutional Holders of BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI) as of Q2 2025
As of 30 Jun 2025,
BioXcel Therapeutics, Inc. - Common Stock, par value $0.001 per share (BTAI) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
603,081 shares.
The largest 10 holders included
OAKTREE CAPITAL MANAGEMENT LP, Murchinson Ltd., Oaktree Fund Advisors, LLC, UBS Group AG, GEODE CAPITAL MANAGEMENT, LLC, JONES FINANCIAL COMPANIES LLLP, HighTower Advisors, LLC, XTX Topco Ltd, Beacon Pointe Advisors, LLC, and VANGUARD GROUP INC.
This page lists
34
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
31
Q2 2025 holders
33
Holder diff
2
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.